HealthcareAI Research5 min reading time

🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery

Latent.Space
Read full post
At the 2026 JPM Pharma conference, Chai Discovery, backed by OpenAI and valued at $4B, emerged as a key player in AI-powered drug discovery tools. Their advancements have reached a trust level enabling pharma teams to scale and innovate drug design, including complex antibody engineering.

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes
Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources